Livzon Pharmaceutical Group (000513.SZ) Stock Price
Livzon Pharmaceutical Group Price
Over the last 19 years Livzon Pharmaceutical Group grew revenue by 11.2% annually, reaching 11.91 B CNY. Earnings per share have grown at 13.2% per year over the last 19 years. For Livzon Pharmaceutical Group, the net margin of 17.0% is up versus 14.7% a few years ago. At today's price the dividend yield works out to roughly 4.08%. The payout ratio is around 48% of earnings. The dividend has grown at 11.4% per year over the past 17 years. The consensus 12-month price target for Livzon Pharmaceutical Group is 45.65 CNY, about 69.2% above where the stock trades today. Of 9 analysts, 6 rate the stock a buy — an overall Buy consensus.
Livzon Pharmaceutical Group stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Livzon Pharmaceutical Group business model & stock analysis
Frequently asked questions about Livzon Pharmaceutical Group
The business model of Livzon Pharmaceutical Group Inc focuses on pharmaceutical manufacturing and sales. Livzon Pharmaceutical Group Inc is a company that specializes in the research, development, production, and sale of pharmaceutical products. Operating in the healthcare sector, Livzon Pharmaceutical Group Inc aims to provide high-quality and effective medical solutions to meet the needs of patients worldwide. With a strong emphasis on innovation and quality control, Livzon Pharmaceutical Group Inc strives to improve healthcare outcomes and contribute to the well-being of individuals.
Livzon Pharmaceutical Group Inc is primarily active in the pharmaceutical industry. As a renowned company, Livzon Pharmaceutical Group Inc is engaged in the research, development, production, and distribution of a wide range of pharmaceutical products. With a strong focus on innovation and quality, Livzon Pharmaceutical Group Inc provides various healthcare solutions, including prescription drugs, over-the-counter medications, and medical devices. With its extensive portfolio and expertise in the pharmaceutical sector, Livzon Pharmaceutical Group Inc has made significant contributions to improving healthcare and enhancing the well-being of individuals worldwide.
The main competitors of Livzon Pharmaceutical Group Inc in the market include multinational pharmaceutical companies such as Pfizer, Novartis, and Johnson & Johnson. These companies also operate in the same industry, manufacturing and distributing a wide range of pharmaceutical products and medications. Livzon Pharmaceutical Group Inc faces competition from these established players in terms of product innovation, market share, and global presence. In order to remain competitive, Livzon Pharmaceutical Group Inc focuses on its research and development capabilities, commercial partnerships, and strategic alliances to differentiate itself in the market.
Livzon Pharmaceutical Group Inc is a leading pharmaceutical company based in China. Founded in 1992, Livzon has established itself as a major player in the healthcare industry, specializing in research, development, manufacturing, and marketing of pharmaceutical products. With a strong focus on innovation and quality, Livzon offers a diverse range of prescription drugs, over-the-counter medications, and healthcare products to meet the needs of patients and consumers worldwide. Over the years, Livzon has achieved significant milestones and expanded its presence both domestically and internationally. Today, Livzon Pharmaceutical Group Inc continues to strive for excellence in delivering safe and effective medical solutions for global healthcare challenges.
Livzon Pharmaceutical Group Inc, a leading pharmaceutical company, has achieved several significant milestones. Over the years, Livzon Pharmaceutical Group Inc has successfully developed and launched a wide range of innovative and high-quality pharmaceutical products. The company has demonstrated continuous growth and expansion, establishing a strong presence both domestically and internationally. Livzon Pharmaceutical Group Inc has also made significant investments in research and development, leading to breakthroughs in the medical field. With a strong commitment to healthcare and an impressive track record, Livzon Pharmaceutical Group Inc remains at the forefront of the pharmaceutical industry, striving to improve global health and well-being.
Livzon Pharmaceutical Group Inc is primarily present in China. The company, headquartered in Zhuhai, Guangdong province, operates mainly within the domestic market. Specializing in the research, development, manufacturing, and marketing of pharmaceutical products, Livzon serves customers across various provinces and cities in China. With a wide range of therapeutic areas covered, including traditional Chinese medicine, Livzon Pharmaceutical Group Inc is committed to contributing to the health and well-being of the Chinese population through its innovative pharmaceutical offerings.
Livzon Pharmaceutical Group Inc represents values of integrity, innovation, and dedication to the well-being of patients. With a strong corporate philosophy focused on research and development, Livzon strives to provide high-quality pharmaceutical products and services. The company emphasizes ethical business practices and adheres to strict quality standards in order to deliver safe and effective medicines. By continuously promoting technological advancements and investing in talent, Livzon aims to contribute positively to the healthcare industry, while prioritizing the needs of patients. This commitment to excellence is evident in every aspect of Livzon Pharmaceutical Group Inc's operations, making it a trusted name in the pharmaceutical sector.
Analysts currently set an average price target of 44.68 CNY for the Livzon Pharmaceutical Group stock (median: 45.65 CNY), implying +65.7 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Livzon Pharmaceutical Group stock: 6 recommend buying, 2 holding and 1 selling. For 2026, analysts expect Livzon Pharmaceutical Group to generate revenue of 10.60 B CNY and earnings per share of 2.04 CNY.
Converted at the current exchange rate, the Livzon Pharmaceutical Group share trades at 3.61 EUR (26.97 CNY).
The Livzon Pharmaceutical Group share (000513.SZ) is listed on 1 stock exchanges, including: Shenzhen (000513.SZ).
Livzon Pharmaceutical Group Inc is a pharmaceutical company based in China that specializes in the manufacturing, selling, and marketing of medicines and healthcare products. The company was founded in 1985 and has since grown to become one of the leading Chinese pharmaceutical companies. The business model of Livzon includes several divisions. The main divisions of the company involve the manufacturing and selling of prescription and over-the-counter drugs, medical devices, and healthcare products, as well as research and development of new medicines and therapies. Livzon produces a wide range of medicines including anti-cancer drugs, antiviral drugs, antibiotics, hormone preparations, immunomodulators, and cardiovascular drugs. These drugs are sold under various brand names and are available on the Chinese and international market. The company also has a division for medical devices including diagnosis, monitoring, and therapy devices. The focus here is on products for cardiology, neuroscience, and emergency medicine. Livzon also produces healthcare products including vitamins, dietary supplements, and drugs for improving physical performance. Livzon is also heavily involved in research and development of new medicines and therapies. The company has a team of experts and researchers who continuously work on developing new and more effective treatments for various diseases. Livzon Pharmaceutical Group Inc has a strong distribution network that spans across China and the international market. The company distributes its products through a wide network of distribution partners, retailers, and online platforms. As a rapidly growing company, Livzon Pharmaceutical Group Inc has experienced high growth rates in revenue and profit in recent years. The company also has a strong financial foundation and is well positioned to continue growing and expanding into new markets. Overall, Livzon Pharmaceutical Group Inc has a successful business model that focuses on the production of high-quality and effective medicines and healthcare products, as well as the development of new therapies. With a strong distribution network and a solid financial foundation, the company is in an excellent position to continue growing and increasing its market presence.
The expected revenue of Livzon Pharmaceutical Group is 10.60 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Livzon Pharmaceutical Group is 1.81 B CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Livzon Pharmaceutical Group is currently 13.20. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Livzon Pharmaceutical Group stock.
The price-to-sales ratio (P/S) of Livzon Pharmaceutical Group is currently 2.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Livzon Pharmaceutical Group stock.
The Eulerpool Quality Score for Livzon Pharmaceutical Group is 5/10.
The ISIN of Livzon Pharmaceutical Group is CNE0000002Y8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Livzon Pharmaceutical Group is 000513.SZ. The ticker symbol is used to trade Livzon Pharmaceutical Group shares on the stock exchange.
Livzon Pharmaceutical Group stock
Livzon Pharmaceutical Group Peer Group
Livzon Pharmaceutical Group Ticker
Livzon Pharmaceutical Group FIGI
All fundamentals and in-depth analysis of Livzon Pharmaceutical Group
Our stock analysis for Livzon Pharmaceutical Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Livzon Pharmaceutical Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.